Balentine LLC Novo Nordisk A S Transaction History

Balentine LLC

$2.54 Billion
Q3 2024

A detailed history of Balentine LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Balentine LLC holds 12,481 shares of NVO stock, worth $1.09 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

12,481

Previous 12,479 0.02%

Holding current value

$1.09 Million

Previous $1.78 Million 16.56%

% of portfolio

0.06%

Previous 0.08%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$119.07 - $145.42 $238 - $290	2 Added 0.02%	12,481 $1.49 Million
Q2 2024 Aug 07, 2024	SELL	$122.71 - $146.91 $8.68 Million - $10.4 Million	-70,700 Reduced 85.0%	12,479 $1.78 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $191,456 - $254,849	1,875 Added 2.31%	83,179 $10.7 Million
Q4 2023 Feb 09, 2024	BUY	$87.78 - $105.45 $1.12 Million - $1.34 Million	12,741 Added 18.58%	81,304 $8.41 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $3.15 Million - $6.91 Million	34,612 Added 101.95%	68,563 $6.24 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $156,291 - $172,995	1,002 Added 3.04%	33,951 $5.49 Million
Q1 2023 May 11, 2023	BUY	$132.34 - $159.14 $72,389 - $87,049	547 Added 1.69%	32,949 $5.24 Million
Q4 2022 Jan 31, 2023	BUY	$102.55 - $135.33 $594,174 - $784,102	5,794 Added 21.78%	32,402 $4.38 Million
Q3 2022 Oct 26, 2022	SELL	$95.28 - $116.93 $892,868 - $1.1 Million	-9,371 Reduced 26.05%	26,608 $2.65 Million
Q2 2022 Oct 26, 2022	BUY	$103.24 - $121.81 $1.04 Million - $1.23 Million	10,076 Added 38.9%	35,979 $4.01 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $3.71 Million - $4.38 Million	35,979 New	35,979 $4.01 Million
Q1 2022 Oct 26, 2022	SELL	$93.1 - $112.54 $938,075 - $1.13 Million	-10,076 Reduced 28.01%	25,903 $2.88 Million
Q4 2021 Oct 26, 2022	SELL	$95.88 - $117.08 $1.82 Million - $2.22 Million	-18,969 Reduced 52.72%	17,010 $1.91 Million
Q4 2021 Feb 02, 2022	SELL	$95.88 - $117.08 $1.29 Million - $1.57 Million	-13,430 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $309,821 - $391,295	3,670 Added 37.6%	13,430 $1.29 Million
Q2 2021 Aug 16, 2021	BUY	$67.66 - $84.76 $76,117 - $95,355	1,125 Added 13.03%	9,760 $818,000
Q1 2021 May 10, 2021	BUY	$67.06 - $75.82 $10,528 - $11,903	157 Added 1.85%	8,635 $582,000
Q4 2020 Feb 08, 2021	BUY	$63.89 - $73.8 $7,858 - $9,077	123 Added 1.47%	8,478 $592,000
Q3 2020 Nov 02, 2020	BUY	$63.69 - $70.22 $412,838 - $455,166	6,482 Added 346.08%	8,355 $580,000
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $109,645 - $127,251	1,873 New	1,873 $123,000
Q4 2019 Sep 02, 2020	SELL	$49.86 - $58.26 $64,369 - $75,213	-1,291 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $6,082 - $6,821	130 Added 11.2%	1,291 $66,000
Q4 2018 Feb 13, 2019	BUY	$41.54 - $47.25 $8,141 - $9,261	196 Added 20.31%	1,161 $53,000
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $45,123 - $49,446	965 New	965 $45,000
Q1 2018 May 16, 2018	SELL	$48.49 - $58.14 $34,815 - $41,744	-718 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$41.15 - $49.22 $29,545 - $35,339	718	718 $35,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Account